Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Medite Cancer Diagnostics, Inc. (MDIT)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11Dec-31-10
   10-K10-K10-K/A10-K/A10-K/A10-K10-K10-K
Revenues:  
    United States  0.70.91.01.30.7   
    Poland  0.20.20.00.0    
    Germany    8.99.6    
    Other  5.98.18.9 9.3   
Total revenues   [+]6.89.29.911.010.00.20.00.0
            Revenue growth   [+]-26.3%-6.6%-10.0%10.3%4929.3%725.0%-20.0%-31.8%
Cost of goods sold  6.75.66.17.25.70.10.60.0
Gross profit  0.23.63.83.84.20.1-0.60.0
            Gross margin  2.4%39.3%38.5%34.8%42.3%47.5%-2500.0%96.7%
Selling, general and administrative  8.10.25.92.81.11.01.71.7
Research and development  1.21.51.31.20.90.30.20.2
Other operating expenses  -3.03.4-2.9 1.6   
EBITDA   [+]-6.2-1.4-0.4-0.20.5-1.1-2.2-1.5
            EBITDA margin  -90.8%-15.7%-4.3%-2.0%5.0%-533.3%-9100.0%-4863.3%
Depreciation and amortization  0.30.20.20.20.20.20.40.4
EBIT   [+]-6.5-1.7-0.6-0.40.3-1.3-2.6-1.9
            EBIT margin  -95.1%-18.0%-6.1%-3.6%3.0%-640.9%-10633.3%-6170.0%
Non-recurring items   [+]      0.00.4
Interest expense, net   [+]0.80.70.20.30.00.00.00.1
Other income (expense), net   [+]0.00.10.00.1-0.3-0.2-0.30.2
Pre-tax income  -7.3-2.3-0.8-0.60.1-1.5-2.9-2.1
Income taxes  -0.5-0.10.10.10.00.00.00.0
            Tax rate  6.7%5.8%  26.0%0.0%0.0%0.0%
Net income  -6.9-2.3-0.9-0.80.1-1.8-3.1-2.4
            Net margin  -101.3%-24.4%-9.5%-7.4%0.5%-899.0%-13091.7%-7876.7%
   
Basic EPS   [+]($0.26)($0.11)($0.05)($0.04)$0.00($0.02)($0.05)($0.05)
Diluted EPS   [+]($0.26)($0.11)($0.05)($0.04)$0.00($0.02)($0.05)($0.05)
   
Shares outstanding (basic)   [+]26.421.420.218.114.772.258.245.7
Shares outstanding (diluted)   [+]26.421.420.218.114.772.258.245.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy